Thyrotropin receptor antibody activities significantly correlate with the outcome of radioiodine (131I) therapy for hyperthyroid Graves' disease.

K Kaise; N Kaise; K Yoshida; H Fukazawa; K Mori; M Yamamoto; T Sakurada; S Saito; K Yoshinaga

doi:10.1507/endocrj1954.38.429

Thyrotropin receptor antibody activities significantly correlate with the outcome of radioiodine (131I) therapy for hyperthyroid Graves' disease.

Identifier:nobleid.org/w1/20260515/15FDFEE0

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/15FDFEE0.svg?ark=w1%2F20260515%2F15FDFEE0)](https://nobleid.org/work/w1/20260515/15FDFEE0)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Thyrotropin receptor antibody activities significantly correlate with the outcome of radioiodine (131I) therapy for hyperthyroid Graves' disease.

Identifier:nobleid.org/w1/20260515/15FDFEE0

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/15FDFEE0.svg?ark=w1%2F20260515%2F15FDFEE0)](https://nobleid.org/work/w1/20260515/15FDFEE0)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work